These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1174026

  • 1. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ, Geiger W, Schulz KD, Lose KH.
    Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
    [Abstract] [Full Text] [Related]

  • 2. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ, Josimovich JB, Archer DF.
    Am J Obstet Gynecol; 1975 May 01; 122(1):85-9. PubMed ID: 1168997
    [Abstract] [Full Text] [Related]

  • 3. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM, Kletzky OA, Davajan V.
    Fertil Steril; 1977 May 01; 28(5):521-5. PubMed ID: 404198
    [Abstract] [Full Text] [Related]

  • 4. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM, Siler-Khodr TM.
    Am J Obstet Gynecol; 1977 Feb 01; 127(3):291-8. PubMed ID: 576372
    [Abstract] [Full Text] [Related]

  • 5. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K, Seki M, Okumura T.
    Acta Endocrinol (Copenh); 1975 May 01; 79(1):25-33. PubMed ID: 1173307
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE, Khojandi M, Huth J, Smith B, Thomas P.
    Am J Obstet Gynecol; 1975 Feb 01; 121(3):375-9. PubMed ID: 1115151
    [Abstract] [Full Text] [Related]

  • 7. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M, Rydner T, Carlström K.
    Acta Obstet Gynecol Scand; 1980 Feb 01; 59(2):137-41. PubMed ID: 6773290
    [Abstract] [Full Text] [Related]

  • 8. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP, Stone SC.
    Obstet Gynecol; 1976 Jul 01; 48(1):84-9. PubMed ID: 934580
    [Abstract] [Full Text] [Related]

  • 9. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M, L'Hermite M, Hedouin-Quincampoix M, Fossati P.
    Acta Endocrinol (Copenh); 1977 Apr 01; 84(4):738-49. PubMed ID: 322432
    [Abstract] [Full Text] [Related]

  • 10. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C, Telloli P, Rampini P, Caldara R.
    Gynecol Obstet Invest; 1980 Apr 01; 11(6):317-26. PubMed ID: 6785158
    [Abstract] [Full Text] [Related]

  • 11. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G, Schonauer S, Lodico G, Lotti G, Delitala G, Masala A.
    Minerva Ginecol; 1976 Oct 01; 28(10):761-70. PubMed ID: 1036769
    [Abstract] [Full Text] [Related]

  • 12. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M, de Villamizar M.
    Fertil Steril; 1982 Mar 01; 37(3):392-6. PubMed ID: 6800849
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB, Corenblum B, Pairaudeau N, Ezrin C, Adamson GD.
    Am J Obstet Gynecol; 1980 Mar 01; 136(5):652-8. PubMed ID: 7188835
    [Abstract] [Full Text] [Related]

  • 16. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG.
    South Med J; 1977 Jun 01; 70(6):720-1, 725. PubMed ID: 577621
    [Abstract] [Full Text] [Related]

  • 17. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE, Reighlin S.
    N Engl J Med; 1975 Aug 28; 293(9):451-2. PubMed ID: 1171365
    [No Abstract] [Full Text] [Related]

  • 18. Galactorrhea-amenorrhea syndromes: etiology and treatment.
    Spark RF, Pallotta J, Naftolin F, Clemens R.
    Ann Intern Med; 1976 May 28; 84(5):532-7. PubMed ID: 945033
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use.
    Tyson JE, Andreasson B, Huth J, Smith B, Zacur H.
    Obstet Gynecol; 1975 Jul 28; 46(1):1-11. PubMed ID: 1153129
    [Abstract] [Full Text] [Related]

  • 20. The effect of lergotrile on galactorrhea and gonadotropin secretion.
    Cleary RE, Crabtree R, Lemberger L.
    J Clin Endocrinol Metab; 1975 May 28; 40(5):830-3. PubMed ID: 165221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.